Arkolith/Insider Trading/OKYO/Form 4

Cerrone Gabriele M

Executive Chairman, DirectorOKYO Pharma Ltd (OKYO) · full profile →Form 4 · filed Oct 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2023Other(J)70K$1.50$105K9.2M
Oct 23, 2023Other(J)499K$1.50$749K9.1M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-038854) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML